Search research articles
Contact Us
Filters
Showing results (1-10 of 159) with videos related to
Page
of 16
Sort By:
Seminars in Reproductive Medicine
|
June 28, 2007
X chromosome and ovarian failure
Daniela Toniolo, Flavio Rizzolio
Seminars in Cell & Developmental Biology
|
October 14, 2022
Microfluidic organoids-on-a-chip: The future of human models
Gloria Saorin, Isabella Caligiuri, Flavio Rizzolio
ACS Medicinal Chemistry Letters
|
June 18, 2014
Fluorescent carbon nanoparticles in medicine for cancer therapy
Vinit Kumar, Giuseppe Toffoli, Flavio Rizzolio
Frontiers in Oncology
|
September 12, 2022
The history of small extracellular vesicles and their implication in cancer drug resistance
Stefano Palazzolo, Vincenzo Canzonieri, Flavio Rizzolio
Cancers
|
August 7, 2021
Cancer Organoids in Basic Science and Translational Medicine
Lorenzo Memeo, Vincenzo Canzonieri, Flavio Rizzolio
ACS Medicinal Chemistry Letters
|
January 20, 2018
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update
Reshma Rani, Vinit Kumar, Flavio Rizzolio
Journal of Cellular Biochemistry
|
August 21, 2012
Emerging molecular networks in Burkitt's lymphoma
Davide Mangani, Annalisa Roberti, Flavio Rizzolio, et al.
Journal of Cellular Physiology
|
November 23, 2011
Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets
Giuseppe Corona, Flavio Rizzolio, Antonio Giordano, et al.
Oncotarget
|
August 1, 2013
pRb controls estrogen receptor alpha protein stability and activity
Isabella Caligiuri, Giuseppe Toffoli, Antonio Giordano, et al.
Journal of Medicinal Chemistry
|
July 2, 2021
α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases
Giulia Bononi, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Page
of 16
Search research articles
Search
Showing results (1-10 of 159) with videos related to
Sort By:
Page
of 16
Seminars in Reproductive Medicine
|
June 28, 2007
X chromosome and ovarian failure
Daniela Toniolo, Flavio Rizzolio
Seminars in Cell & Developmental Biology
|
October 14, 2022
Microfluidic organoids-on-a-chip: The future of human models
Gloria Saorin, Isabella Caligiuri, Flavio Rizzolio
ACS Medicinal Chemistry Letters
|
June 18, 2014
Fluorescent carbon nanoparticles in medicine for cancer therapy
Vinit Kumar, Giuseppe Toffoli, Flavio Rizzolio
Frontiers in Oncology
|
September 12, 2022
The history of small extracellular vesicles and their implication in cancer drug resistance
Stefano Palazzolo, Vincenzo Canzonieri, Flavio Rizzolio
Cancers
|
August 7, 2021
Cancer Organoids in Basic Science and Translational Medicine
Lorenzo Memeo, Vincenzo Canzonieri, Flavio Rizzolio
ACS Medicinal Chemistry Letters
|
January 20, 2018
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update
Reshma Rani, Vinit Kumar, Flavio Rizzolio
Journal of Cellular Biochemistry
|
August 21, 2012
Emerging molecular networks in Burkitt's lymphoma
Davide Mangani, Annalisa Roberti, Flavio Rizzolio, et al.
Journal of Cellular Physiology
|
November 23, 2011
Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets
Giuseppe Corona, Flavio Rizzolio, Antonio Giordano, et al.
Oncotarget
|
August 1, 2013
pRb controls estrogen receptor alpha protein stability and activity
Isabella Caligiuri, Giuseppe Toffoli, Antonio Giordano, et al.
Journal of Medicinal Chemistry
|
July 2, 2021
α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases
Giulia Bononi, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Page
of 16